Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database.
<h4>Background</h4>Drug-induced autoimmune-like hepatitis (DI-ALH) is a potentially life-threatening condition that can lead to acute liver failure and necessitate liver transplantation. While the association between certain drugs and DI-ALH has been documented, a comprehensive analysis...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0317680 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823856804879138816 |
|---|---|
| author | Wangyu Ye Yuan Ding Meng Li Zhihua Tian Shaoli Wang Zhen Liu |
| author_facet | Wangyu Ye Yuan Ding Meng Li Zhihua Tian Shaoli Wang Zhen Liu |
| author_sort | Wangyu Ye |
| collection | DOAJ |
| description | <h4>Background</h4>Drug-induced autoimmune-like hepatitis (DI-ALH) is a potentially life-threatening condition that can lead to acute liver failure and necessitate liver transplantation. While the association between certain drugs and DI-ALH has been documented, a comprehensive analysis of drug-related signals in a large, real-world pharmacovigilance database is lacking. This study aimed to systematically identify drugs linked to DI-ALH by analyzing adverse event reports from the U.S. Food and Drug Administration's (FDA) Adverse Event Reporting System (FAERS) database.<h4>Methods</h4>We searched the FAERS database for the term "autoimmune hepatitis" and extracted DI-ALH reports from the first quarter of 2004 to the first quarter of 2024. Positive signal drugs were identified using Proportional Reporting Ratio (PRR), Reporting Odds Ratio (ROR), Bayesian Confidence Propagation Neural Network (BCPNN), and Empirical Bayesian Geometric Mean (EBGM). To confirm a significant drug-adverse event association, each method had to meet predefined thresholds: for PRR and ROR, values were considered significant if the lower 95% confidence interval (CI) was greater than 1 and at least three reports were identified; for BCPNN, an Information Component (IC025) greater than 0 indicated a signal; for EBGM, a value greater than 2 for the lower 95% confidence interval (EBGM05) was used to denote a positive signal.<h4>Results</h4>A total of 5,723 DI-ALH reports were extracted from the FAERS database. Disproportionality analysis identified 50 drugs with strong associations to DI-ALH, with biologics, statins, antibiotics, and antiviral drugs representing the most common categories. Among these, nitrofurantoin (ROR 94.79, CI 78.53-114.41), minocycline (ROR 77.82, CI 65.09-93.05), and nivolumab (ROR 47.12, CI 15.06-147.39) exhibited the strongest signals. Additionally, several previously unreported drugs, including mesalazine, aldesleukin, onasemnogene abeparvovec-xioi, and nefazodone, were identified as having strong associations with DI-ALH. These findings were consistent across all four signal detection methods, further validating the robustness of the associations.<h4>Conclusion</h4>This study provides a comprehensive assessment of drugs associated with DI-ALH through a rigorous analysis of the FAERS database using multiple signal detection methods. By identifying both well-known and previously underreported drugs, this study contributes to a more complete understanding of drug-induced liver injury. The findings have important implications for pharmacovigilance strategies and clinical risk assessment. However, limitations inherent in the FAERS database, such as underreporting and the potential for reporting bias, should be considered. Further clinical validation is warranted to confirm these associations. |
| format | Article |
| id | doaj-art-1d3310019b864306aab36b232f9160ff |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-1d3310019b864306aab36b232f9160ff2025-02-12T05:30:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01202e031768010.1371/journal.pone.0317680Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database.Wangyu YeYuan DingMeng LiZhihua TianShaoli WangZhen Liu<h4>Background</h4>Drug-induced autoimmune-like hepatitis (DI-ALH) is a potentially life-threatening condition that can lead to acute liver failure and necessitate liver transplantation. While the association between certain drugs and DI-ALH has been documented, a comprehensive analysis of drug-related signals in a large, real-world pharmacovigilance database is lacking. This study aimed to systematically identify drugs linked to DI-ALH by analyzing adverse event reports from the U.S. Food and Drug Administration's (FDA) Adverse Event Reporting System (FAERS) database.<h4>Methods</h4>We searched the FAERS database for the term "autoimmune hepatitis" and extracted DI-ALH reports from the first quarter of 2004 to the first quarter of 2024. Positive signal drugs were identified using Proportional Reporting Ratio (PRR), Reporting Odds Ratio (ROR), Bayesian Confidence Propagation Neural Network (BCPNN), and Empirical Bayesian Geometric Mean (EBGM). To confirm a significant drug-adverse event association, each method had to meet predefined thresholds: for PRR and ROR, values were considered significant if the lower 95% confidence interval (CI) was greater than 1 and at least three reports were identified; for BCPNN, an Information Component (IC025) greater than 0 indicated a signal; for EBGM, a value greater than 2 for the lower 95% confidence interval (EBGM05) was used to denote a positive signal.<h4>Results</h4>A total of 5,723 DI-ALH reports were extracted from the FAERS database. Disproportionality analysis identified 50 drugs with strong associations to DI-ALH, with biologics, statins, antibiotics, and antiviral drugs representing the most common categories. Among these, nitrofurantoin (ROR 94.79, CI 78.53-114.41), minocycline (ROR 77.82, CI 65.09-93.05), and nivolumab (ROR 47.12, CI 15.06-147.39) exhibited the strongest signals. Additionally, several previously unreported drugs, including mesalazine, aldesleukin, onasemnogene abeparvovec-xioi, and nefazodone, were identified as having strong associations with DI-ALH. These findings were consistent across all four signal detection methods, further validating the robustness of the associations.<h4>Conclusion</h4>This study provides a comprehensive assessment of drugs associated with DI-ALH through a rigorous analysis of the FAERS database using multiple signal detection methods. By identifying both well-known and previously underreported drugs, this study contributes to a more complete understanding of drug-induced liver injury. The findings have important implications for pharmacovigilance strategies and clinical risk assessment. However, limitations inherent in the FAERS database, such as underreporting and the potential for reporting bias, should be considered. Further clinical validation is warranted to confirm these associations.https://doi.org/10.1371/journal.pone.0317680 |
| spellingShingle | Wangyu Ye Yuan Ding Meng Li Zhihua Tian Shaoli Wang Zhen Liu Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database. PLoS ONE |
| title | Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database. |
| title_full | Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database. |
| title_fullStr | Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database. |
| title_full_unstemmed | Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database. |
| title_short | Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database. |
| title_sort | drug induced autoimmune like hepatitis a disproportionality analysis based on the faers database |
| url | https://doi.org/10.1371/journal.pone.0317680 |
| work_keys_str_mv | AT wangyuye druginducedautoimmunelikehepatitisadisproportionalityanalysisbasedonthefaersdatabase AT yuanding druginducedautoimmunelikehepatitisadisproportionalityanalysisbasedonthefaersdatabase AT mengli druginducedautoimmunelikehepatitisadisproportionalityanalysisbasedonthefaersdatabase AT zhihuatian druginducedautoimmunelikehepatitisadisproportionalityanalysisbasedonthefaersdatabase AT shaoliwang druginducedautoimmunelikehepatitisadisproportionalityanalysisbasedonthefaersdatabase AT zhenliu druginducedautoimmunelikehepatitisadisproportionalityanalysisbasedonthefaersdatabase |